Log book

Mass Customization (MC) is becoming a significant market trend, notably in the food industry. MC can be applied to extrinsic characteristics like packaging and design but also to intrinsic elements such as recipes and ingredients. Why do many companies show interest for Mass Customization? Because it can be advantageous for them in different ways! Alcimed digs in to four key benefits of MC to show you how it can improve the competitiveness of your company.

Alcimed discusses battle plans as Humanity wages a world war against #COVID-19, as the pressure builds in the West. This week, whereas the course of the pandemic is difficult to predict, technology is serving the needs of mankind, and the first treatment options are being put forward. To get your Alcivax #4, click on the […]

Since the 2000s, scientific interest in the microbiota has been growing steadily, particularly in the United States and Europe. After the intestinal microbiota success, bacteria and other microorganisms are now living their glory days in the cosmetics world. The skin microbiota is particularly successful. Many cosmetics players are positioning themselves on the subject. Alcimed sheds light on these small bacteria with great assets for the cosmetic industry.

Cancer will soon be death cause number 1 on a global level representing strong unmet medical needs and enormous costs for healthcare systems. New, innovative treatments and technologies as well as personalization of treatments are required in order to drastically improve the patients’ situation and cure cancer one day.

Many aquaculture 4.0 innovations are now available on the market. With such beneficial innovations available, the focus now should be to increase adoption. Here, we discuss examples and strategies to increase aquaculture 4.0 adoption in the Asia-Pacific region, which produces 86% of the world’s aquaculture output by value.

Alcivax #3 – 20 March 2020. Alcimed demonstrates the efficacy of human solidarity in a time of crisis and why we will beat the pandemic in the end.

What does it mean to live in a post-antibiotic era? In the 1944, antibiotics began to be mass produced creating a world in which people no longer routinely died of bacterial infection. In a post-antibiotic era, we no longer live with that guarantee. This hardly means we should throw our hands up in defeat! Stakeholders from across human health from food to pharma will be required to help navigate this global threat. Alcimed outlines the key hallmarks of this new era to create perspective on the scope of the problem.

Profound changes are impacting our societies, from population growth and aging to global warming, social inequalities and socio-demographic imbalances. The agricultural world, which is undergoing significant transformations, must also adapt and respond to these changes. These are complex challenges to address as they are interdependent and require the joint action of all players, from businesses to public institutions, including farmers and consumer-citizens. The Alcimed’s French Agri-Food team reviews three of the main issues currently faced by the agricultural sector.

Alcivax #2 – 12 March 2020. Alcimed’s healthcare team digests all the COVID-19 coronavirus science, tech and industry news to keep you from burning out before the outbreak does.

Carbon Capture, Utilization and Storage, or CCUS, is in the spotlight nowadays in the industry. Still, between utilization – that consists in reusing the CO2 as a feedstock in the industry – and storage – that consists in sequestering it in the subsurface – the gap is considerable. Behind these two solutions lie two distinct visions of how to reduce carbon footprint. Alcimed shares some tracks of reflection.